NT5E and neoplasm: CD73 is also expressed on lung cancer cells, as well as on tumor-promoting mesenchymal stromal cells and myeloid-derived suppressor cells in tumor tissue from NSCLC patients, and has been identified as a prognostic factor for poor overall survival and recurrence-free NSCLC survival (42–44).